B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®

Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.

Hip Replacement Devices Market Size, Share, Trends, Scope & Forecast

Apheresis Machines Market 2021: Comprehensive Study Explores

Hip Replacement Devices Market Size, Share, Trends, Scope & Forecast

Apheresis Machines Market 2021: Comprehensive Study Explores

Digital Diabetes Management Market Size, Trends & Forecast

Digital Diabetes Management Market Size, Trends & Forecast

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®

In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum

新闻详情页-B. Braun Group